FON: THE BUSINESS OF INTEGRATIVE HEALTH & MEDICINE

A Patient’s Perspective on the Atlantic’s “The Triumph of New Age Medicine”

By Glenn Sabin Photo on left by Stephen Webster, as seen in the Atlantic article: The Triumph of New Age Medicine (Note: For those of you who missed David H. Freedman’s piece in the July 2011 edition of the Atlantic, I urge you to read it and the debate that followed.  This post was originally intended as a response to appear on the Atlantic’s Web site, but that debate has since closed.) I have employed an

5 Reasons Why Content is King for Growing Integrative Medicine Services

By Glenn Sabin   Does your center have a content creation and distribution strategy? Consumers interested in a patient-centered approach to their healthcare spend a lot of time learning about preventive medicine and general wellness.  When they or a family member face a health challenge, they are quick to consult the Web for their health information needs.  So when it comes to evidence-based integrative medicine, your center or clinic has a

Leveraging the Science

By Glenn Sabin Most integrative medicine clinics and centers do a poor job communicating to their patients and prospective patients about the evidence supporting their clinical recommendations and interventions. While it’s accurate to say that the science base for integrative medicine is a mere fraction of that for conventional interventions and pharmaceuticals, the amount of quality research and positive outcomes is growing steadily. Now is the time for integrative centers to

Integrative Oncology Featured at ASCO Annual 2011 Meeting

By Glenn Sabin Integrative oncology research and discussions will be featured prominently during the ASCO 2011 Annual Meeting this weekend in Chicago, with several presenters among Society for Integrative Oncology leadership. After many years advocating for integrative oncology research to be presented at the meeting, I am pleased to note that evidence-based complementary interventions are becoming part of the vanguard for oncology care, driven be consumer demand and a growing science base. The